Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2210]

$A new CAR-T therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma$

A new CAR-T therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma

TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits in patients with certain types of bladder cancer

TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits...

TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC

TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk...

Nivolumab subcutaneous formulation given approval across multiple solid tumour types in the UK

Nivolumab subcutaneous formulation given approval across multiple solid tumour types in the UK

Drug dismantles a metabolic barrier to anti-tumour immunity

Drug dismantles a metabolic barrier to anti-tumour immunity

Radioiodine therapy improves relative survival rates of differentiated thyroid cancer patients

Radioiodine therapy improves relative survival rates of differentiated thyroid cancer patients

FDA approves penpulimab-kcqx for non-keratinizing nasopharyngeal carcinoma

FDA approves penpulimab-kcqx for non-keratinizing nasopharyngeal carcinoma

NICE approves dual immunotherapy for the first line treatment of adult patients with mismatch repair deficient or microsatellite instability high unresectable or metastatic colorectal cancer approved in the UK

NICE approves dual immunotherapy for the first line treatment of adult patients with mismatch repair deficient or...

For colon cancer that no longer responds to treatment, a new drug combination offers hope

For colon cancer that no longer responds to treatment, a new drug combination offers hope

Liquid biopsy: A breakthrough technology in early cancer screening

Liquid biopsy: A breakthrough technology in early cancer screening

More from ecancer